KR920000306B1 - 니모디핀-함유 제제의 제조방법 - Google Patents

니모디핀-함유 제제의 제조방법 Download PDF

Info

Publication number
KR920000306B1
KR920000306B1 KR1019840002390A KR840002390A KR920000306B1 KR 920000306 B1 KR920000306 B1 KR 920000306B1 KR 1019840002390 A KR1019840002390 A KR 1019840002390A KR 840002390 A KR840002390 A KR 840002390A KR 920000306 B1 KR920000306 B1 KR 920000306B1
Authority
KR
South Korea
Prior art keywords
weight
nimodipine
solvent
ethanol
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019840002390A
Other languages
English (en)
Korean (ko)
Other versions
KR840009031A (ko
Inventor
호프 디터
Original Assignee
바이엘 아크티엔 게젤샤프트
귄터 슈마허, 에리히 데브리츠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이엘 아크티엔 게젤샤프트, 귄터 슈마허, 에리히 데브리츠 filed Critical 바이엘 아크티엔 게젤샤프트
Publication of KR840009031A publication Critical patent/KR840009031A/ko
Application granted granted Critical
Publication of KR920000306B1 publication Critical patent/KR920000306B1/ko
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
KR1019840002390A 1983-05-06 1984-05-03 니모디핀-함유 제제의 제조방법 Expired KR920000306B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3316510.6 1983-05-06
DE19833316510 DE3316510A1 (de) 1983-05-06 1983-05-06 Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen

Publications (2)

Publication Number Publication Date
KR840009031A KR840009031A (ko) 1984-12-24
KR920000306B1 true KR920000306B1 (ko) 1992-01-11

Family

ID=6198265

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840002390A Expired KR920000306B1 (ko) 1983-05-06 1984-05-03 니모디핀-함유 제제의 제조방법

Country Status (19)

Country Link
US (1) US5114956A (cg-RX-API-DMAC7.html)
EP (1) EP0126315B1 (cg-RX-API-DMAC7.html)
JP (1) JPS59206305A (cg-RX-API-DMAC7.html)
KR (1) KR920000306B1 (cg-RX-API-DMAC7.html)
AT (1) ATE24835T1 (cg-RX-API-DMAC7.html)
AU (1) AU562293B2 (cg-RX-API-DMAC7.html)
BE (1) BE899564A (cg-RX-API-DMAC7.html)
CA (1) CA1220424A (cg-RX-API-DMAC7.html)
DE (2) DE3316510A1 (cg-RX-API-DMAC7.html)
DK (1) DK164148C (cg-RX-API-DMAC7.html)
ES (1) ES531995A0 (cg-RX-API-DMAC7.html)
FR (1) FR2545354B1 (cg-RX-API-DMAC7.html)
GR (1) GR81609B (cg-RX-API-DMAC7.html)
HK (1) HK75889A (cg-RX-API-DMAC7.html)
IL (1) IL71744A (cg-RX-API-DMAC7.html)
IT (1) IT1181804B (cg-RX-API-DMAC7.html)
PT (1) PT78542B (cg-RX-API-DMAC7.html)
SG (1) SG44489G (cg-RX-API-DMAC7.html)
ZA (1) ZA843352B (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
AT387518B (de) * 1985-12-18 1989-02-10 Bayer Ag Verfahren zur herstellung von fluessigen spruehpraeparaten von dihydropyridinen
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
DE3702105A1 (de) * 1987-01-24 1988-08-04 Bayer Ag Parenterale loesung
GB2228412B (en) * 1989-02-28 1993-04-14 Syntex Inc Nicardipine pharmaceutical composition for parenteral administration
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
US6492332B1 (en) 1995-12-12 2002-12-10 Omeros Corporation Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
RU2180852C2 (ru) * 1994-12-12 2002-03-27 Омерос Медикл Системс, Инк. Ингибирующий раствор и способ подавления боли, воспаления или спазма
AU4467396A (en) 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
US6413961B1 (en) 1995-12-12 2002-07-02 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain and inflammation
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
US8034762B2 (en) * 2004-09-02 2011-10-11 Cognosci, Inc. Treatment of subarachnoid hemorrhage with Apo E analogs
EP1933837A4 (en) * 2005-10-14 2009-07-15 Transform Pharmaceuticals Inc PHARMACEUTICAL LIQUID COMPOSITIONS OF NIMODIPIN
EP2015730A1 (de) * 2006-04-28 2009-01-21 Basf Se Verfahren zur solubilisierung von hydrophoben wirkstoffen in wässrigem medium
US8728504B2 (en) 2010-02-05 2014-05-20 Basf Se Process for solubilizing hydrophobic active ingredients in aqueous medium
EP2531548A1 (de) 2010-02-05 2012-12-12 Basf Se Verfahren zur solubilisierung von hydrophoben wirkstoffen in wässrigem medium
AU2012250050B2 (en) 2011-04-28 2017-04-06 Platform Brightworks Two, Ltd. Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
US10092553B2 (en) 2016-04-13 2018-10-09 Nortic Holdings Inc. Stable nimodipine parenteral formulation
CN114886850A (zh) * 2016-04-13 2022-08-12 格雷斯疗法公司 尼莫地平制剂及治疗病症的方法
EP3755326A4 (en) 2018-02-22 2021-11-03 Nortic Holdings Inc. STABLE PARENTERAL FORMULATION OF NIMODIPINE
US12414943B2 (en) 2022-05-16 2025-09-16 Grace Therapeutics U.S., Inc. Nimodipine parenteral administration
CN117502433A (zh) * 2023-11-08 2024-02-06 中国科学院海洋研究所 一种水母刺丝囊存放保护剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2650013C3 (de) * 1976-10-30 1981-04-02 Bayer Ag, 5090 Leverkusen 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
AU2758384A (en) 1984-11-08
EP0126315A1 (de) 1984-11-28
DK224184D0 (da) 1984-05-04
ATE24835T1 (de) 1987-01-15
ES8505542A1 (es) 1985-06-01
FR2545354B1 (fr) 1986-09-26
PT78542B (en) 1986-07-14
DE3316510A1 (de) 1984-11-08
JPH0422888B2 (cg-RX-API-DMAC7.html) 1992-04-20
EP0126315B1 (de) 1987-01-14
GR81609B (cg-RX-API-DMAC7.html) 1984-12-11
HK75889A (en) 1989-09-29
IL71744A (en) 1988-04-29
BE899564A (fr) 1984-11-05
JPS59206305A (ja) 1984-11-22
SG44489G (en) 1989-11-17
US5114956A (en) 1992-05-19
KR840009031A (ko) 1984-12-24
IT8448139A0 (it) 1984-05-04
DE3461988D1 (en) 1987-02-19
IT1181804B (it) 1987-09-30
DK164148C (da) 1992-10-26
AU562293B2 (en) 1987-06-04
FR2545354A1 (fr) 1984-11-09
DK224184A (da) 1984-11-07
ZA843352B (en) 1984-12-24
ES531995A0 (es) 1985-06-01
IL71744A0 (en) 1984-09-30
CA1220424A (en) 1987-04-14
IT8448139A1 (it) 1985-11-04
PT78542A (en) 1984-06-01
DK164148B (da) 1992-05-18

Similar Documents

Publication Publication Date Title
US5114956A (en) Parenteral formulation of nimodipine
US4798846A (en) Pharmaceutical compositions
US4452817A (en) Anaesthetic compositions containing 2,6-diisopropylphenol
KR100359556B1 (ko) 티릴라자드의조용매비경구제
EP0652751B1 (en) Injection and injection kit containing omeprazole and its analogs
KR100735788B1 (ko) 일반 염을 함유하는 목시플록사신 제형
KR100402570B1 (ko) 주사용퀴놀론제제
JPS61268625A (ja) ポリエン抗生物質エマルジヨン製剤
US20070203357A1 (en) Freeze-dried product of n-[o-(p-pivaloyloxy benzenesulfonylamino) benzoyl]glycine monosodium salt tetra-hydrate and a process for the manufacture thereof
US4185093A (en) Preparation and method for treatment of hypocalcemia, hypophosphatemia and downer cow syndrome in animals
JP3502574B2 (ja) 眼感染症治療用眼軟膏剤
GB2076288A (en) Antitumor compositions
US5084276A (en) Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
JPH0692853A (ja) 注射剤および注射剤キット
EP0213676B1 (en) Pharmaceutical compositions containing acth (1-24) for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies
US6841576B2 (en) Anti-hypertensive composition and methods of treatment
EP0317624B1 (en) Thyrotropin-releasing hormone analogs in cns injury
US4666926A (en) Transdermal formulations
JPH06263636A (ja) 脳または高次神経疾患治療剤
US4425348A (en) Antitumor compositions
EP0005074A1 (en) A material and composition for reducing blood pressure
US4794104A (en) Pharmaceutical compositions containing ACTH fragments for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies
JPS6344517A (ja) 非経口的投与用溶液
JP2946015B2 (ja) 安定な抗ウィルス点滴用注射剤
US4089949A (en) Injectable therapeutic compositions

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

O035 Opposition [patent]: request for opposition
PO0301 Opposition

St.27 status event code: A-2-3-E10-E11-opp-PO0301

Opposition date: 19920311

Opposition reference: 101992001293

Opposition grounds text: 01

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

PO1301 Decision on opposition

St.27 status event code: A-3-3-W10-W00-opp-PO1301

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

FPAY Annual fee payment

Payment date: 20030106

Year of fee payment: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20040112

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20040112

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000